Assessment of the Pharmacokinetics and Safety of ANT3310 Combined With Meropenem in Renally Impaired Subjects

Clinical trial NCT06527677 · COMPLETED

Trial details

NCT number: NCT06527677
Sponsor: Antabio
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Impairment

Start date: 2024-07-19
Primary completion: 2025-07-03
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.